XML 51 R38.htm IDEA: XBRL DOCUMENT v3.24.2.u1
OTHER CURRENT LIABILITIES (Tables)
 6 Months Ended
Jun. 30, 2024
Other Liabilities Disclosure [Abstract]  
Schedule of Other Current Liabilities
Other current liabilities consist of the following:
(US$ in millions)June 30,
2024		December 31,
2023
Unrealized losses on derivative contracts, at fair value$1,046 $1,038 
Accrued liabilities700 865 
Advances on sales (1)
364 463 
Dividends payable (2)
289 96 
Income tax payable115 238 
Disposition deposit (3)
103 — 
Other306 213 
Total$2,923 $2,913 
(1)    The Company records advances on sales when cash payments are received in advance of the Company’s performance and recognizes revenue once the related performance obligation is completed. Advances on sales are impacted by the seasonality of Bunge's business, including the timing of harvests in the northern and southern hemispheres, and amounts at each balance sheet date will generally be recognized in earnings within twelve months or less.
(2)    See Note 17 - Equity.
(3)    On June 19, 2024, Bunge entered into a definitive share purchase agreement to sell its 50% ownership share in BP Bunge Bioenergia. During the quarter, Bunge received a refundable deposit towards the closing purchase price of $103 million. See Note 2 - Acquisitions and Dispositions.